Company intelligence / Profile preview

CMIC Group

Minato-ku, Tokyo, Japanen.cmicgroup.com ↗

Ownership: Private
Employees: ~7000
Development stage: Commercial

Overview

CMIC Group provides end-to-end solutions for pharmaceutical development including non-clinical studies, clinical trials from Phase I–IV, regulatory consulting, manufacturing services for investigational and commercial products, site management solutions, sales/marketing support in Japan/Asia/US. They enable global pharma/biotech companies to accelerate drug development and market entry in Japan and Asia. They do not report their own clinical results as they are not developing proprietary therapeutics.

Modalities: Small moleculeBiologicCell therapyGene therapyMedical device
Industry: Contract Research Organization

Beyond the preview

Go deeper on CMIC Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMIC Group.

Explore the full profile